365
Participants
Start Date
November 12, 2008
Primary Completion Date
December 31, 2011
Study Completion Date
April 15, 2013
RAD001(everolimus)
10 mg qd
interferon alfa-2a
dose escalated from 3 MIU (million international unit) during week 1, 6 MIU during week 2, and 9 MIU during week 3
bevacizumab
10 mg/kg every 2 weeks
Novartis Investigative Site, Taipei
Novartis Investigative Site, Taipei
Novartis Investigative Site, Brussels
Novartis Investigative Site, Budapest
Novartis Investigative Site, Budapest
Novartis Investigative Site, Brussels
Novartis Investigative Site, Johannesburg
Novartis Investigative Site, Leuven
Novartis Investigative Site, Bern
Novartis Investigative Site, Liège
Novartis Investigative Site, Charleroi
Novartis Investigative Site, Chur
Novartis Investigative Site, Kortrijk
Novartis Investigative Site, Taipei
Novartis Investigative Site, Berlin
Novartis Investigative Site, Bangkok
Novartis Investigative Site, Berlin
Novartis Investigative Site, Caen
Novartis Investigative Site, Bursa
Novartis Investigative Site, Milan
Novartis Investigative Site, Hamburg
Novartis Investigative Site, Jaén
Novartis Investigative Site, Brescia
Novartis Investigative Site, Cremona
Novartis Investigative Site, Pavia
Novartis Investigative Site, Madrid
Novartis Investigative Site, Madrid
Novartis Investigative Site, Hanover
Novartis Investigative Site, Toulouse
Novartis Investigative Site, Bordeaux
Novartis Investigative Site, Aviano
Novartis Investigative Site, Linkou District
Novartis Investigative Site, Montellier Cedex 5
Novartis Investigative Site, Mecidiyekoy/Istanbul
Novartis Investigative Site, Altunizade
Novartis Investigative Site, Balcova / Izmir
Novartis Investigative Site, Negrar
Novartis Investigative Site, Göttingen
Novartis Investigative Site, Trento
Novartis Investigative Site, Santander
Novartis Investigative Site, Santander
Novartis Investigative Site, Taichung
Novartis Investigative Site, Modena
Novartis Investigative Site, Nantes
Novartis Investigative Site, Essen
Karmanos Cancer Institute Dept.of KarmanosCancerInst (5), Detroit
Novartis Investigative Site, Zaragoza
Novartis Investigative Site, Florence
Novartis Investigative Site, Reims
Novartis Investigative Site, Mainz
Novartis Investigative Site, Frankfurt
Novartis Investigative Site, Frankfurt
Novartis Investigative Site, Strasbourg
Novartis Investigative Site, Strasbourg
Novartis Investigative Site, Heidelberg
Novartis Investigative Site, Tübingen
Highlands Oncology Group Dept of Highlands Oncology Grp, Fayetteville
Las Colinas Hematology Oncology Grapevine, Irving
Novartis Investigative Site, Rouen
Novartis Investigative Site, Napoli
Novartis Investigative Site, Avignon
Novartis Investigative Site, La Roche-sur-Yon
Novartis Investigative Site, Catanzaro
Nevada Cancer Institute Dept. of Nevada Cancer (3), Las Vegas
USC/Kenneth Norris Comprehensive Cancer Center Regulatory Contact 3, Los Angeles
University of California at Los Angeles Dept. of Hem/Oncology, Los Angeles
Novartis Investigative Site, Songkhla
Novartis Investigative Site, Suresnes
Seattle Cancer Care Alliance Dept. of SCCA, Seattle
Novartis Investigative Site, Moscow
Novartis Investigative Site, Moscow
Novartis Investigative Site, Saint Petersburg
Novartis Investigative Site, Saint Petersburg
Novartis Investigative Site, Obninsk
Novartis Investigative Site, Singapore
City of Hope National Medical Center Dept.ofCityofHopeMedicalCtr(3), Duarte
St. Luke's Hospital and Health Network St. Luke's Cancer Network, Bethlehem
Novartis Investigative Site, Cairo
Novartis Investigative Site, Cairo
Novartis Investigative Site, Shatin, New Territories
Novartis Investigative Site, Tuenmen
Novartis Investigative Site, Rio de Janeiro
Novartis Investigative Site, Porto Alegre
Novartis Investigative Site, Porto Alegre
Novartis Investigative Site, Ribeirão Preto
Novartis Investigative Site, Santo André
Novartis Investigative Site, São Paulo
Novartis Investigative Site, Olomouc
Novartis Investigative Site, Prague
Novartis Investigative Site, Dessau
Novartis Investigative Site, Leipzig
Novartis Investigative Site, Perugia
Novartis Investigative Site, Roma
Novartis Investigative Site, Roma
Novartis Investigative Site, Leiden
Novartis Investigative Site, Pretoria
Novartis Investigative Site, Pretoria
Novartis Investigative Site, Goyang-si
Novartis Investigative Site, Seoul
Novartis Investigative Site, Daegu
Novartis Investigative Site, Seoul
Novartis Investigative Site, Taegu
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Adana
Novartis Investigative Site, Ankara
Novartis Investigative Site, Antalya
Novartis Investigative Site, Northwood
Novartis Investigative Site, Glasgow
Novartis Investigative Site, Southampton
Lead Sponsor
Roche Pharma AG
INDUSTRY
Novartis Pharmaceuticals
INDUSTRY